Health

Seoul National University Hospital Showcases Koreas Next-Generation Medical Technologies at MEDICA 2025

SEOUL, South Korea, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Seoul National University Hospital (SNUH) is set to lead Korea’s participation…

3 weeks ago

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

November 11, 2025 07:05 ET  | Source: Zenas BioPharma WALTHAM, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.…

4 weeks ago

AC Immune to Present at the Jefferies 2025 London Healthcare Conference

AC Immune to Present at the Jefferies 2025 London Healthcare Conference Lausanne, Switzerland, November 11, 2025 -- AC Immune SA…

4 weeks ago

Ernexa Therapeutics to Present at Oxford Globals Cell 2025

Sanjeev Luther, President and CEO to give an oral presentation and participate in a moderated panel discussion November 11, 2025…

4 weeks ago

Glaucoma 360 2026: Where Science, Innovation, and Collaboration Shape the Future of Vision

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today announced the 15th annual Glaucoma 360 event,…

4 weeks ago

NTG Nordic Transport Group publishes interim report for Q3 2025

Company announcement no. 10 – 25 10 November 2025 NTG Nordic Transport Group publishes interim report for Q3 2025 The…

4 weeks ago

Genmab Provides Certain Information Disclosed in Connection with Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes

Media Release COPENHAGEN, Denmark; November 10, 2025 Genmab A/S (“Genmab”) announced on November 10, 2025, that it and its wholly…

4 weeks ago

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

Multicenter outcomes FISH&CHIPS study of nearly 8,000 patients confirms total plaque volume as a powerful independent predictor of long-term cardiovascular…

4 weeks ago

George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Associations Scientific Sessions 2025

London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs…

4 weeks ago

Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025

November 09, 2025 09:00 ET  | Source: Medera Inc. BOSTON, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a…

4 weeks ago